The Recall Desk
SevereFDA (Drugs)·D-0573-2018·Announced 2018-02-07

Baxter Recalls Nexterone Injection Due to Polyethylene Particulate Matter

Baxter Healthcare is recalling Nexterone (amiodarone HCl) Premixed Injection because polyethylene particulate matter was identified in the product packaging.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The agency classification is FDA Class I, which mandates a minimum severity score of 4 according to the rubric.

Plain-English summary

Baxter Healthcare Corporation is recalling 35,628 single-dose containers of Nexterone (amiodarone HCl) Premixed Injection, 150mg/100mL. The recall was initiated because particulate matter was identified in the product. The particulate has been identified as polyethylene, which is the primary constituent of the film and ports used to manufacture the bag in which the product is packaged.

The affected product is a prescription-only, sterile, intravenous injection. The specific lots involved are NC109925 (Exp 6/1/2019) and NC109123 (Exp 5/2019). The product was distributed nationwide within the USA and Puerto Rico.

Healthcare providers and patients should stop using the affected lots of Nexterone. Baxter Healthcare is the recalling firm responsible for managing the recall.

The recalled product

Product
NEXTERONE (AMIODARONE HYDROCHLORIDE)
Brand
NEXTERONE
Affected units
35,628

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (5)

  • Lot #
  • Expiry: NC109925
  • Exp 6/1/2019
  • NC109123
  • 5/2019

Distribution

Distributed nationwide across the United States.

The notice also names 1 state specifically: